These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 3083041)
41. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies. Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155 [TBL] [Abstract][Full Text] [Related]
42. A pharmacological analysis of the effects of (+)-AJ 76 and (+)-UH 232 at release regulating pre- and postsynaptic dopamine receptors. Gifford AN; Johnson KM Eur J Pharmacol; 1993 Jun; 237(2-3):169-75. PubMed ID: 8103459 [TBL] [Abstract][Full Text] [Related]
44. The enantiomers of the dopamine agonist N-0437: in vivo and in vitro effects on the release of striatal dopamine. Timmerman W; Dubocovich ML; Westerink BH; De Vries JB; Tepper PG; Horn AS Eur J Pharmacol; 1989 Jul; 166(1):1-11. PubMed ID: 2572424 [TBL] [Abstract][Full Text] [Related]
45. Synergistic interactions between the NMDA antagonist dizocilpine and the preferential dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 with regard to locomotor stimulation in monoamine-depleted mice. Svensson A; Carlsson M; Carlsson A J Neural Transm Gen Sect; 1991; 85(1):69-77. PubMed ID: 1867840 [TBL] [Abstract][Full Text] [Related]
46. Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Hjorth S; Carlsson A; Clark D; Svensson K; Wikström H; Sanchez D; Lindberg P; Hacksell U; Arvidsson LE; Johansson A Psychopharmacology (Berl); 1983; 81(2):89-99. PubMed ID: 6415751 [TBL] [Abstract][Full Text] [Related]
47. The effects of the enantiomers of the dopamine agonist N-0437 on food consumption and yawning behaviour in rats. Timmerman W; Rusk IN; Tepper P; Horn AS; Cooper SJ Eur J Pharmacol; 1989 Dec; 174(1):107-14. PubMed ID: 2575532 [TBL] [Abstract][Full Text] [Related]
48. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Tricklebank MD; Forler C; Fozard JR Eur J Pharmacol; 1984 Nov; 106(2):271-82. PubMed ID: 6241568 [TBL] [Abstract][Full Text] [Related]
49. Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo. Sonesson C; Boije M; Svensson K; Ekman A; Carlsson A; Romero AG; Martin IJ; Duncan JN; King LJ; Wikström H J Med Chem; 1993 Oct; 36(22):3409-16. PubMed ID: 8230131 [TBL] [Abstract][Full Text] [Related]
51. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity. Millan MJ; Bervoets K; Colpaert FC J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033 [TBL] [Abstract][Full Text] [Related]
53. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum. Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500 [TBL] [Abstract][Full Text] [Related]
54. Increased dopamine turnover in the ventral striatum by 8-OH-DPAT administration in the rat. Ahlenius S; Hillegaart V; Wijkström A J Pharm Pharmacol; 1990 Apr; 42(4):285-8. PubMed ID: 1974300 [TBL] [Abstract][Full Text] [Related]
55. Effect of 8-hydroxy-2-(di-n-propylamino) tetralin on rat prolactin secretion. Simonovic M; Gudelsky GA; Meltzer HY J Neural Transm; 1984; 59(2):143-9. PubMed ID: 6233394 [TBL] [Abstract][Full Text] [Related]
56. Rotational behavior induced by 8-hydroxy-DPAT, a putative 5HT-1A agonist, in 6-hydroxydopamine-lesioned rats. Gerber R; Altar CA; Liebman JM Psychopharmacology (Berl); 1988; 94(2):178-82. PubMed ID: 2965396 [TBL] [Abstract][Full Text] [Related]
57. The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Hjorth S; Magnusson T Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):463-71. PubMed ID: 2469021 [TBL] [Abstract][Full Text] [Related]
58. (S)-UH-301 antagonizes (R)-8-OH-DPAT-induced cardiovascular effects in the rat. Björk L; Lindgren S; Hacksell U; Lewander T Eur J Pharmacol; 1991 Jul; 199(3):367-70. PubMed ID: 1833212 [TBL] [Abstract][Full Text] [Related]
59. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761 [TBL] [Abstract][Full Text] [Related]
60. Pharmacological profile of a chromanamine analogue (DP-6OH-3CA) of the selective presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin. Vermue NA; Dijkstra D; Horn AS J Pharm Pharmacol; 1988 Aug; 40(8):574-7. PubMed ID: 2907015 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]